MetabolicRETATRUTIDE
20MG
$175
Description
Higher concentration Retatrutide for extended metabolic research protocols. This 20MG formulation provides double the supply for longer study durations. Retatrutide's unique triple agonist mechanism targeting GLP-1, GIP, and glucagon receptors simultaneously represents the cutting edge of metabolic peptide research, offering the most comprehensive approach to metabolic regulation currently available. The higher concentration supports researchers conducting extended protocols or dose-escalation studies.
Potential Benefits
Research Notes
This higher-dose formulation supports the extended research protocols used in the landmark Phase 2 trial (NEJM, 2023). Clinical data demonstrated dose-dependent efficacy over 48 weeks, with the highest dose group achieving the most significant metabolic improvements, supporting the need for higher-concentration formulations in comprehensive research.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.